Skip to main content
. 2017 Oct 12;8(18):3682–3688. doi: 10.7150/jca.20017

Figure 2.

Figure 2

Forest plot of postprogression survival subgroup analyses. Only 11 patients received definitive local therapy and analysis was not possible. TKI: tyrosine kinase inhibitor; PD: progressive disease; SD: stable disease; PFS: progression-free survival